{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:49:52Z","timestamp":1792979392718,"version":"4.5.0"},"reference-count":37,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/wwav3590","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:50:56Z","timestamp":1764924656000},"page":"8869-8882","source":"Crossref","is-referenced-by-count":4,"title":["Silymarin attenuates cardiac injury and inflammation in adjuvant-induced rheumatoid arthritis rats through activation of the Nrf2\/SLC7A11\/GPX4 signaling pathway"],"prefix":"10.62347","volume":"17","author":[{"given":"Jia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Matteo A","year":"2023","unstructured":"Di Matteo A, Bathon JM and Emery P. Rheumatoid arthritis. Lancet 2023; 402: 2019-2033.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Brown P, Pratt AG and Hyrich KL. Therapeutic advances in rheumatoid arthritis. BMJ 2024; 384: e070856.","DOI":"10.1136\/bmj-2022-070856"},{"key":"ref2","unstructured":"Jayatilleke A. Arthritis: rheumatoid arthritis. FP Essent 2025; 548: 25-30."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/art.41613","article-title":"Divergence of cardiovascular biomarkers of lipids and subclinical myocardial injury among rheumatoid arthritis patients with increased inflammation","volume":"73","author":"Weber","year":"2021","unstructured":"Weber B, He Z, Yang N, Playford MP, Weisenfeld D, Iannaccone C, Coblyn J, Weinblatt M, Shadick N, Di Carli M, Mehta NN, Plutzky J and Liao KP. Divergence of cardiovascular biomarkers of lipids and subclinical myocardial injury among rheumatoid arthritis patients with increased inflammation. Arthritis Rheumatol 2021; 73: 970-979.","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1033644","DOI":"10.3389\/fcvm.2023.1033644","article-title":"Rheumatoid arthritis and coronary atherosclerosis: a two-sample Mendelian randomization study","volume":"10","author":"Nie","year":"2023","unstructured":"Nie Q, Luo Q, Yan W, Zhang T, Wang H and Wu J. Rheumatoid arthritis and coronary atherosclerosis: a two-sample Mendelian randomization study. Front Cardiovasc Med 2023; 10: 1033644.","journal-title":"Front Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/rheumatology\/key057","article-title":"High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis","volume":"57","author":"Karpouzas","year":"2018","unstructured":"Karpouzas GA, Estis J, Rezaeian P, Todd J and Budoff MJ. High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis. Rheumatology (Oxford) 2018; 57: 1080-1088.","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/1756-185X.12999","article-title":"New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis","volume":"20","author":"Mahmoudi","year":"2017","unstructured":"Mahmoudi M, Aslani S, Fadaei R and Jamshidi AR. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. Int J Rheum Dis 2017; 20: 287-297.","journal-title":"Int J Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/life13020319","article-title":"Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy","volume":"13","author":"Popescu","year":"2023","unstructured":"Popescu D, Rezus E, Badescu MC, Dima N, Seritean Isac PN, Dragoi IT and Rezus C. Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy. Life (Basel) 2023; 13: 319.","journal-title":"Life (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules27165327","article-title":"Mechanistic insights into the pharmacological significance of silymarin","volume":"27","author":"Wadhwa","year":"2022","unstructured":"Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V, Singh I, Kaushik D and Jeandet P. Mechanistic insights into the pharmacological significance of silymarin. Molecules 2022; 27: 5327.","journal-title":"Molecules"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"111109","DOI":"10.1016\/j.isci.2024.111109","article-title":"The clinical anti-inflammatory effects and underlying mechanisms of silymarin","volume":"27","author":"Zhao","year":"2024","unstructured":"Zhao Y, Zhou Y, Gong T, Liu Z, Yang W, Xiong Y, Xiao D, Cifuentes A, Ibanez E and Lu W. The clinical anti-inflammatory effects and underlying mechanisms of silymarin. iScience 2024; 27: 111109.","journal-title":"iScience"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/antiox13010098","article-title":"Silymarin and inflammation: food for thoughts","volume":"13","author":"Surai","year":"2024","unstructured":"Surai PF, Surai A and Earle-Payne K. Silymarin and inflammation: food for thoughts. Antioxidants (Basel) 2024; 13: 98.","journal-title":"Antioxidants (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2174\/0115733971266397231122080247","article-title":"Efficacy and mechanisms of silybum marianum, silymarin, and silibinin on rheumatoid arthritis and osteoarthritis symptoms: a systematic review","volume":"20","author":"Ghahfarrokhi","year":"2024","unstructured":"Ghahfarrokhi SH, Heidari-Soureshjani S, Sherwin CMT and Azadegan-Dehkordi Z. Efficacy and mechanisms of silybum marianum, silymarin, and silibinin on rheumatoid arthritis and osteoarthritis symptoms: a systematic review. Curr Rheumatol Rev 2024; 20: 414-425.","journal-title":"Curr Rheumatol Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.33549\/physiolres.932703","article-title":"Silymarin component 2,3-dehydrosilybin attenuates cardiomyocyte damage following hypoxia\/reoxygenation by limiting oxidative stress","volume":"64","author":"Gabrielov&#xE1","year":"2015","unstructured":"Gabrielová E, Křen V, Jabůrek M and Modrianský M. Silymarin component 2,3-dehydrosilybin attenuates cardiomyocyte damage following hypoxia\/reoxygenation by limiting oxidative stress. Physiol Res 2015; 64: 79-91.","journal-title":"Physiol Res"},{"key":"ref13","unstructured":"Rao PR and Viswanath RK. Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. Exp Clin Cardiol 2007; 12: 179-187."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"9929687","DOI":"10.1155\/2021\/9929687","article-title":"Ferroptosis: opportunities and challenges in myocardial ischemia-reperfusion injury","volume":"2021","author":"Zhao","year":"2021","unstructured":"Zhao WK, Zhou Y, Xu TT and Wu Q. Ferroptosis: opportunities and challenges in myocardial ischemia-reperfusion injury. Oxid Med Cell Longev 2021; 2021: 9929687.","journal-title":"Oxid Med Cell Longev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1080\/21655979.2021.1995994","article-title":"Naringenin alleviates myocardial ischemia\/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)\/system xc-\/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis","volume":"12","author":"Xu","year":"2021","unstructured":"Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H and Xu D. Naringenin alleviates myocardial ischemia\/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)\/system xc-\/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 2021; 12: 10924-10934.","journal-title":"Bioengineered"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"115185","DOI":"10.1016\/j.biopha.2023.115185","article-title":"Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2\/Slc7a11\/Gpx4 axis","volume":"165","author":"Ding","year":"2023","unstructured":"Ding S, Duanmu X, Xu L, Zhu L and Wu Z. Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2\/Slc7a11\/Gpx4 axis. Biomed Pharmacother 2023; 165: 115185.","journal-title":"Biomed Pharmacother"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"9603271221074334","DOI":"10.1177\/09603271221074334","article-title":"Silymarin protects the rats against paraquat-induced acute kidney injury via Nrf2","volume":"41","author":"Jia","year":"2022","unstructured":"Jia C, Zhang Z, Wang J and Nie Z. Silymarin protects the rats against paraquat-induced acute kidney injury via Nrf2. Hum Exp Toxicol 2022; 41: 9603271221074334.","journal-title":"Hum Exp Toxicol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12964-024-01479-z","article-title":"Mitochondria-derived methylmalonic acid aggravates ischemia-reperfusion injury by activating reactive oxygen species-dependent ferroptosis","volume":"22","author":"Guo","year":"2024","unstructured":"Guo J, Wang S, Wan X, Liu X, Wang Z, Liang C, Zhang Z, Wang Y, Yan M, Wu P, Fang S and Yu B. Mitochondria-derived methylmalonic acid aggravates ischemia-reperfusion injury by activating reactive oxygen species-dependent ferroptosis. Cell Commun Signal 2024; 22: 53.","journal-title":"Cell Commun Signal"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3892\/mmr.2020.11815","article-title":"Propofol ameliorates endotoxin-induced myocardial cell injury by inhibiting inflammation and apoptosis via the PPARγ\/HMGB1\/NLRP3 axis","volume":"23","author":"Zhao","year":"2021","unstructured":"Zhao H, Gu Y and Chen H. Propofol ameliorates endotoxin-induced myocardial cell injury by inhibiting inflammation and apoptosis via the PPARγ\/HMGB1\/NLRP3 axis. Mol Med Rep 2021; 23: 176.","journal-title":"Mol Med Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"754784","DOI":"10.3389\/fcvm.2021.754784","article-title":"Circulating biomarkers and cardiac structure and function in rheumatoid arthritis","volume":"8","author":"Kobayashi","year":"2021","unstructured":"Kobayashi M, Ferreira MB, Costa RQ, Fonseca T, Oliveira JC, Marinho A, Carvalho HC, Girerd N, Rossignol P, Zannad F, Rodrigues P and Ferreira JP. Circulating biomarkers and cardiac structure and function in rheumatoid arthritis. Front Cardiovasc Med 2021; 8: 754784.","journal-title":"Front Cardiovasc Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s11897-024-00682-w","article-title":"Heart failure in rheumatoid arthritis: clinical implications","volume":"21","author":"Zambrano Zambrano","year":"2024","unstructured":"Zambrano Zambrano A, Del Rio Zanatta H, Gonzalez Espinoza A, Bernal Alferes B, Zambrano Zambrano K, Martinez Salazar J and Ixcamparij Rosales CH. Heart failure in rheumatoid arthritis: clinical implications. Curr Heart Fail Rep 2024; 21: 530-540.","journal-title":"Curr Heart Fail Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ptr.6361","article-title":"Safety and toxicity of silymarin, the major constituent of milk thistle extract: an updated review","volume":"33","author":"Soleimani","year":"2019","unstructured":"Soleimani V, Delghandi PS, Moallem SA and Karimi G. Safety and toxicity of silymarin, the major constituent of milk thistle extract: an updated review. Phytother Res 2019; 33: 1627-1638.","journal-title":"Phytother Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ijms24010095","article-title":"The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation","volume":"24","author":"Moudgil","year":"2022","unstructured":"Moudgil KD and Venkatesha SH. The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation. Int J Mol Sci 2022; 24: 95.","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1038\/s41598-018-21674-6","article-title":"Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats","volume":"8","author":"Tong","year":"2018","unstructured":"Tong WW, Zhang C, Hong T, Liu DH, Wang C, Li J, He XK and Xu WD. Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats. Sci Rep 2018; 8: 3241.","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/cbin.11079","article-title":"Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1\/Smad signaling","volume":"43","author":"Meng","year":"2019","unstructured":"Meng S, Yang F, Wang Y, Qin Y, Xian H, Che H and Wang L. Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1\/Smad signaling. Cell Biol Int 2019; 43: 65-72.","journal-title":"Cell Biol Int"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Safarpour S, Safarpour S, Moghadamnia AA, Kazemi S, Ebrahimpour A, Shirafkan F, Mansoori R and Golchoobian R. Cardioprotective effect of silymarin nanoemulsion on 5-fluorouracil-induced cardiotoxicity in rats. Arch Pharm (Weinheim) 2022; 355: e2200060.","DOI":"10.1002\/ardp.202200060"},{"key":"ref27","unstructured":"Bayat G, Mazloom R, Hashemi SA, Pourkhalili K, Fallah P, Shams A, Esmaeili P and Khalili A. Silymarin administration attenuates cirrhotic-induced cardiac abnormality in the rats: a possible role of β(1)-adrenergic receptors and L-type voltage-dependent calcium channels. Iran J Med Sci 2022; 47: 367-378."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"175153","DOI":"10.1016\/j.ejphar.2022.175153","article-title":"Silibinin eliminates mitochondrial ROS and restores autophagy through IL6ST\/JAK2\/STAT3 signaling pathway to protect cardiomyocytes from doxorubicin-induced injury","volume":"929","author":"Li","year":"2022","unstructured":"Li W, Qu X, Kang X, Zhang H, Zhang X, Hu H, Yao L, Zhang L, Zheng J, Zheng Y, Zhang J and Xu Y. Silibinin eliminates mitochondrial ROS and restores autophagy through IL6ST\/JAK2\/STAT3 signaling pathway to protect cardiomyocytes from doxorubicin-induced injury. Eur J Pharmacol 2022; 929: 175153.","journal-title":"Eur J Pharmacol"},{"key":"ref29","unstructured":"Okiljevic B, Zdravkovic R, Preveden A, Preveden M, Mladenovic N and Susak S. The effect of silymarin on the prevention of atrial fibrillation after coronary artery bypass grafting. Braz J Cardiovasc Surg 2024; e20230422: e20230422."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R and Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 2019; 23: 101107.","journal-title":"Redox Biol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","article-title":"SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells","volume":"14","author":"Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q, Kondiparthi L, Lei G, Horbath A, Liu X, Mao C, Wu S, Zhuang L, James You M, Poyurovsky MV, Ma L, Olszewski K and Gan B. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun 2023; 14: 3673.","journal-title":"Nat Commun"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, Bassik MC, Nomura DK, Dixon SJ and Olzmann JA. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 2019; 575: 688-692.","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"105466","DOI":"10.1016\/j.phrs.2021.105466","article-title":"Ferroptosis and its emerging roles in cardiovascular diseases","volume":"166","author":"Li","year":"2021","unstructured":"Li N, Jiang W, Wang W, Xiong R, Wu X and Geng Q. Ferroptosis and its emerging roles in cardiovascular diseases. Pharmacol Res 2021; 166: 105466.","journal-title":"Pharmacol Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"103847","DOI":"10.1016\/j.ebiom.2022.103847","article-title":"Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression","volume":"76","author":"Miao","year":"2022","unstructured":"Miao Y, Chen Y, Xue F, Liu K, Zhu B, Gao J, Yin J, Zhang C and Li G. Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression. EBioMedicine 2022; 76: 103847.","journal-title":"EBioMedicine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"102825","DOI":"10.1016\/j.redox.2023.102825","article-title":"EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2","volume":"65","author":"Wang","year":"2023","unstructured":"Wang B, Jin Y, Liu J, Liu Q, Shen Y, Zuo S and Yu Y. EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2. Redox Biol 2023; 65: 102825.","journal-title":"Redox Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"103066","DOI":"10.1016\/j.redox.2024.103066","article-title":"Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation","volume":"70","author":"Zhang","year":"2024","unstructured":"Zhang H, Pan J, Huang S, Chen X, Chang ACY, Wang C, Zhang J and Zhang H. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation. Redox Biol 2024; 70: 103066.","journal-title":"Redox Biol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0166992.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:32:09Z","timestamp":1779345129000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0166992.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/wwav3590","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}